Introduction
Akkermansia muciniphila, a beneficial gut bacterium, has recently emerged as a promising agent in managing various health conditions beyond the gut. This article synthesizes findings from three pivotal clinical trials exploring the efficacy of heat-killed and pasteurized A. muciniphila strains in respiratory symptom relief, muscle strength improvement in elderly adults, and obesity management in dogs. These studies underscore the therapeutic versatility of A. muciniphila-derived postbiotics and their potential integration into clinical practice and dietary supplementation.
